Results 211 to 220 of about 85,887 (297)

Age‐Dependent Differences in Canakinumab Safety: A Comprehensive Pharmacovigilance Analysis Using the FAERS Database

open access: yesPharmacology Research &Perspectives, Volume 14, Issue 3, June 2026.
ABSTRACT While the efficacy of canakinumab, an anti‐interleukin‐1β monoclonal antibody, is well‐established, its safety profile, particularly across different age groups, remains inadequately explored. Using the FDA Adverse Event Reporting System (FAERS) database, this study evaluated postmarketing safety by analyzing adverse event (AE) reports from ...
Youyang Wang   +3 more
wiley   +1 more source

Prevalence and Predisposing Factors of Helicobacter pylori Infection in Symptomatic Patients: A Multicenter Study in Ghana's Upper East Region

open access: yesPublic Health Challenges, Volume 5, Issue 2, June 2026.
A high Helicobacter pylori prevalence of 65.8% was detected among dyspeptic patients in northern Ghana, linked to poor sanitation, use of public toilets, consumption of street‐vended food, and drinking untreated water. These findings underscore the need for targeted public‐health interventions. ABSTRACT Background Helicobacter pylori (H.
Elvis Ramsy Awuni   +2 more
wiley   +1 more source

Early‐Life Nutritional Supplements, Household Environments, and Air Pollution Associated With Children's Helicobacter pylori Infection: A Chinese Multicenter Mother‐Child Study

open access: yesSafety Science and Technology, Volume 1, Issue 2, June 2026.
Early‐life intake of nutritional additives, particularly during pregnancy and the early postnatal period, reduces the risk of Helicobacter pylori infection (HPI) in children by enhancing immune function and preventing gastrointestinal infections through proper nutrition, supporting the “(Pre‐)Fetal origins of HPI” hypothesis through the “gut–uterine ...
Chan Lu   +5 more
wiley   +1 more source

Multimorbidity and the Number of Conditions Increase With the Duration of Type 1 Diabetes and Associate With Increased Mortality

open access: yesJournal of Diabetes, Volume 18, Issue 6, June 2026.
Multimorbidity in type 1 diabetes is common and increases with age and especially diabetes duration. In addition, multimorbidity is associated with increased mortality in type 1 diabetes. ABSTRACT Background Multimorbidity in type 1 diabetes has previously not been studied in detail.
Anni Ylinen   +7 more
wiley   +1 more source

How to Define the Gastroesophageal Junction

open access: yesDigestive Endoscopy, Volume 38, Issue 6, June 2026.
ABSTRACT Adenocarcinomas at the gastroesophageal junction (GEJ) are increasingly common worldwide. Current classifications, such as Siewert type II and Nishi, provide a foundation, but establishing a transparent and widely accepted framework could considerably enhance identification and treatment efforts.
Ken‐ichi Mukaisho   +6 more
wiley   +1 more source

Downstream Treatment Burden and Health‐Care Utilization Following Initiation of GLP‐1 Receptor Agonists or SGLT2 Inhibitors in Type 2 Diabetes

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 6, Page 5163-5173, June 2026.
ABSTRACT Aims Glucagon‐like peptide‐1 (GLP‐1) receptor agonists and sodium–glucose cotransporter 2 (SGLT2) inhibitors are widely used for the treatment of type 2 diabetes, yet their downstream consequences in routine clinical practice remain incompletely characterized.
Yazan Alhamdan   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy